BioStem Technologies Inc. Insider Trading
BSEM
Insiders sold 14K and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. No executive or director has bought shares on the open market in the last two years.
Get an email when BSEM's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17 | Jason Matuszewski Chief Executive Officer | SoldNo plan | 14,300 | $1.00 | 14K | 0.9% | Form 4 |
- Nov 17No planJason MatuszewskiChief Executive Officer · sold 14,300 at $1.0014K0.9% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with BSEM
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing BSEM
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.